Takeda Cuts Jobs And Pushes Oncology After Patent Losses Nudge 2009 Sales Down 4.7%

TOKYO - Takeda continues to see the negative impact of patent loss on key products sold in North America, and coupling that with the strong yen against the U.S. dollar and other currencies, the company reported May 13 revenue decreases of a sharp 4.7 percent in fiscal 2009 - its first sales decline in 19 years